< Back to previous page
Researcher
Steven Simoens
- Disciplines:Biomarker discovery and evaluation, Drug discovery and development, Medicinal products, Pharmaceutics, Pharmacognosy and phytochemistry, Pharmacology, Pharmacotherapy, Toxicology and toxinology, Other pharmaceutical sciences
Affiliations
- Clinical Pharmacology and Pharmacotherapy (Division)
Member
From1 Jul 2013 → Today
Projects
1 - 10 of 22
- How to create sustainable market access to advanced therapies?From1 Jan 2024 → TodayFunding: FWO research project (including WEAVE projects)
- Health Economic Evaluations of Preventive Policies in Flanders (HELPPFL)From22 Nov 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Development, Validation, and Valorization of a Patient Preference Platform to Inform Healthcare Decision-MakingFrom1 Mar 2023 → TodayFunding: IOF - technology validation in lab
- Exploring the market access of advanced therapy medicinal products (ATMPs)From17 Oct 2022 → 9 Sep 2023Funding: Own budget, for example: patrimony, inscription fees, gifts
- STRAtified Dosing based on Augmented renal clearance for CEFtriaxone in patients with severe community-acquired pneumonia: STRADA-CEF trial.From1 Oct 2022 → TodayFunding: FWO Applied Biomedical Research (TBM)
- Exploring the market environment of biologics including biosimilar medicinesFrom20 Sep 2021 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Framework for value driven market access of gene therapyFrom1 Sep 2021 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Unlocking Biosimilar Benefits: An Exploration of Barriers to Biosimilar Adoption, Value Assessment and Market SustainabilityFrom16 Oct 2019 → 13 Dec 2023Funding: Own budget, for example: patrimony, inscription fees, gifts
- A Belgian policy framework for best-value biological medicinesFrom3 Sep 2019 → 18 Sep 2023Funding: Own budget, for example: patrimony, inscription fees, gifts
- Framework for value driven market access of gene therapyFrom1 Sep 2019 → 23 Oct 2020Funding: FWO Strategic Basic Research Grant
Publications
31 - 40 of 426
- Assessing the Value of Nusinersen for Spinal Muscular Atrophy: A Comparative Analysis of Reimbursement Submission and Appraisal in European Countries(2022)
Authors: Alessandra Blonda, Teresa Barcina Lacosta, Steven Simoens
- Perceptions About Biosimilar Medicines Among Belgian Patients in the Ambulatory Care(2022)
Authors: Yannick Vandenplas, Liese Barbier, Steven Simoens, Arnold Vulto, Isabelle Huys
- Amortization of gene replacement therapies: A health policy analysis exploring a mechanism for mitigating budget impact of high-cost treatments(2022)
Authors: Steven Simoens
Pages: 49 - 59 - Sustainable biosimilar competition: clinical, regulatory and policy insights(2021)
Authors: Liese Barbier, Isabelle Huys, Paul Declerck, Steven Simoens
- A Comparative Analysis of Pricing and Reimbursement of Cystic Fibrosis Transmembrane Conductance Regulator Modulators in Europe(2021)
Authors: Khadidja Abdallah, Christiane De Boeck, Steven Simoens
- Patient preferences for gene therapy in haemophilia: Results from the PAVING threshold technique survey(2021)
Authors: Kathelijne Peerlinck, Steven Simoens, Isabelle Huys
Pages: 957 - 966 - R&D Costs of New Medicines: A Landscape Analysis(2021)
Authors: Steven Simoens, Isabelle Huys
- Patient Preferences in Drug Development and Evaluation: Issues and Recommendations(2021)
Authors: Rosanne Janssens, Isabelle Huys, Steven Simoens, Hilde Stevens
- Patient Preferences for Multiple Myeloma Treatments: A Multinational Qualitative Study(2021)
Authors: Rosanne Janssens, Elise Schoefs, Martina Vandebroek, Michel Delforge, Steven Simoens, Isabelle Huys
- Potential approaches for the pricing of cancer medicines across Europe to enhance the sustainability of healthcare systems and the implications(2021)
Authors: Steven Simoens
Pages: 527 - 540